Trevi Therapeutics (TRVI) SEC Filings & 10K Form

$2.73
-0.19 (-6.51%)
(As of 05/10/2024 ET)

Recent Trevi Therapeutics SEC Filings

DateFilerForm TypeView
05/07/2024
3:09 PM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
6:39 PM
Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
03/20/2024
3:08 PM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
3:10 PM
Trevi Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2024
3:12 PM
Trevi Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/16/2024
3:42 PM
SCIASCIA THOMAS (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:43 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:43 PM
Clark David J (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:43 PM
Simon Farrell (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:44 PM
Galletta Christopher (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:42 PM
Delfini Lisa (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:47 PM
Trevi Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G/A
02/14/2024
2:48 PM
Fairmount Funds Management LLC (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
02/14/2024
9:21 AM
Trevi Therapeutics (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G/A
02/12/2024
5:06 AM
Rubric Capital Management LP (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
10/12/2023
3:00 PM
Delfini Lisa (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:06 PM
Delfini Lisa (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
11:15 PM
Trevi Therapeutics (Filer)
Form EFFECT
08/11/2023
3:06 PM
Trevi Therapeutics (Filer)
Form S-3/A
06/30/2023
3:14 PM
Mathers Edward T (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2023
4:06 PM
Trevi Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/21/2023
3:00 PM
Simon Farrell (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
3:28 PM
Delfini Lisa (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:47 PM
Delfini Lisa (Reporting)
Trevi Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TRVI) was last updated on 5/12/2024 by MarketBeat.com Staff

From Our Partners